Click the HTML icon in the toolbar above to edit spacer height.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

IDT's Virtual Summit | Past, Present, and Future of Whole Exome Sequencing

Available on-demand


Yesterday’s limitations are tomorrow’s opportunities. Contribute to knowledge bases, find signatures, and research elusive new cancer mutations with whole exome sequencing tools by IDT. With the most complete coverage, established quality metrics, and a broad range of customizable solutions, IDT’s whole exome sequencing (WES) solutions offer greater confidence for cancer researchers.


Click the HTML icon in the toolbar above to edit spacer height.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

In this multi-session virtual event, attendees will:

  • Learn about the past, present, and future applications of whole exome sequencing.
  • Explore how whole exome sequencing (WES) is advancing new discoveries in oncology, rare disease, and pharmacogenomics research.
  • Discover how labs are successfully incorporating AI technologies within their exome analysis workflows.
  • Hear how researchers are partnering together to create a data-driven ecosystem with whole exome sequencing technology.

Fill out the form below to register.

Click the HTML icon in the toolbar above to edit spacer height.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.
Click the HTML icon in the toolbar above to edit spacer height.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.

Summit Presenters

21_LP_NG_Whole Exome Sequencing Virtual Summit_Presenter-headshot_Bob Fulton.png
Bob Fulton

Director of Technical Development
McDonnell Genome Institute

Bob joined MGI in 1994 and has over 25 years of experience in the field of DNA sequencing and analysis. Throughout his time at MGI, he has led production-based targeted sequence efforts as well as the sequence improvement (finishing) pipelines responsible for genome sequence refinement.

21_LP_NG_Whole Exome Sequencing Virtual Summit_Presenter-headshot_Hua Bao.png
Hua Bao, PhD

Director of R&D
Geneseeq

Dr. Bao is responsible for the development of new NGS testing products, computational methods, and mathematical modelling in cancer genomics. Dr. Bao holds more than 10 patents and has published numerous papers in peer reviewed journals, including Gut, Journal of Thoracic Oncology, Clinical Cancer Research, Oncogene, and Bioinformatics. He is also an active member of ASCO and AACR.


21_LP_NG_Whole Exome Sequencing Virtual Summit_Presenter-headshot_Matthias Begermann.png
Matthias Begemann, PhD

Head of Laboratory—NGS Diagnostics Center
UK Aachen

Dr. Begermann received his undergraduate degree in biology from the Heinrich Heine University, Düsseldorf, Germany and Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen. He later completed his thesis on human molecular genetics/epigentics with a focus on imprinting disorders like Silver-Russel syndrome. He then completed post-doctoral research at the Institute of Human Genetics, RWTH Aachen University Hospital.

21_LP_NG_Whole Exome Sequencing Virtual Summit_Presenter-headshot_Ruben.png
Ruben Attali, PhD

Director of Customer Success and Lead Scientist
Emedgene

Highly experienced and well-published researcher in the genetics of rare diseases. Led a research lab in Sheba Tel Hashomer where he took overall responsibility for budgeting, grant submission, and operational and scientific management. Heads customer success, scientific product development, and scientific collaborations at Emedgene.

21_LP_NG_Whole Exome Sequencing Virtual Summit_Presenter-headshot_Oliver Hampton.png
Oliver Hampton, PhD

VP of Bioinformatics and Biostatistics
M2GEN

Oliver leads the bioinformatics team and is building the biostatistics team to support the Avatar project, as well as collaborative projects between M2GEN, Pharma, and ORIEN partners. Prior to joining M2GEN, he led the Platform Informatics team within the Center for Molecular Oncology at Memorial Sloan Kettering Cancer Center.

21_LP_NG_Whole Exome Sequencing Virtual Summit_Presenter-headshot_Florian Kraft.png
Florian Kraft, PhD

Head of Regulatory Genomics
The Institute of Human Genetics Aachen

Dr. Kraft has held two post-doctoral positions, one at the Institute of Immunology Jena, where he investigated mast cell signaling, and the other at the Institute of Human Genetics Aachen, where he is studying the molecular cause of rare inherited diseases through WES, WGS, nanopore sequencing, and basic molecular techniques. Prior to these roles, Dr. Kraft studied biochemistry and molecular biology at the Friedrich-Schiller-Universität Jena and completed his thesis and PhD on cancer genetics at the Institute of Human Genetics Jena.

21_LP_NG_Whole Exome Sequencing Virtual Summit_Presenter-headshot_Laurentijn Tilleman.png
Laurentijn Tilleman

PhD Student
Faculty of Pharmaceutical Sciences, Ghent University

Laurentijn graduated from the Faculty of Bioscience Engineering of Ghent University in 2016. He is now working on his PhD at the Faculty of Pharmaceutical Sciences of Ghent University in the core facility for next-generation sequencing (NXTGNT). His primary focus is on sequencing analysis in the field of pharmacogenomics.